Belite Bio Adr Stock Alpha and Beta Analysis
| BLTE Stock | USD 63.26 4.18 6.20% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Belite Bio ADR. It also helps investors analyze the systematic and unsystematic risks associated with investing in Belite Bio over a specified time horizon. Remember, high Belite Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Belite Bio's market risk premium analysis include:
Beta 0.68 | Alpha 0.38 | Risk 4.19 | Sharpe Ratio 0.12 | Expected Return 0.51 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Belite |
Belite Bio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Belite Bio market risk premium is the additional return an investor will receive from holding Belite Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Belite Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Belite Bio's performance over market.| α | 0.38 | β | 0.68 |
Belite Bio expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Belite Bio's Buy-and-hold return. Our buy-and-hold chart shows how Belite Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Belite Bio Market Price Analysis
Market price analysis indicators help investors to evaluate how Belite Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Belite Bio shares will generate the highest return on investment. By understating and applying Belite Bio stock market price indicators, traders can identify Belite Bio position entry and exit signals to maximize returns.
Belite Bio Return and Market Media
The median price of Belite Bio for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 55.8 with a coefficient of variation of 21.62. The daily time series for the period is distributed with a sample standard deviation of 13.04, arithmetic mean of 60.32, and mean deviation of 11.44. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Belite Bio Announces First Patient Dosed in Phase 23 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease | 09/10/2024 |
2 | Heres Why Were Not At All Concerned With Belite Bios Cash Burn Situation | 09/24/2024 |
3 | Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting | 10/14/2024 |
4 | Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results | 11/05/2024 |
5 | Belite Bio Reports Q3 2024 Results Progress in Stargardt and Geographic Atrophy Trials | 11/12/2024 |
6 | Belite Bio stock soars to all-time high of 84.2 amid robust gains - Investing.com Australia | 11/14/2024 |
7 | Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007 | 11/27/2024 |
About Belite Bio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Belite or other stocks. Alpha measures the amount that position in Belite Bio ADR has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Belite Bio Upcoming Company Events
As portrayed in its financial statements, the presentation of Belite Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Belite Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Belite Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Belite Bio. Please utilize our Beneish M Score to check the likelihood of Belite Bio's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Belite Bio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Belite Bio Backtesting, Belite Bio Valuation, Belite Bio Correlation, Belite Bio Hype Analysis, Belite Bio Volatility, Belite Bio History and analyze Belite Bio Performance. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Belite Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.